MedPath

广东沙溪制药有限公司

Ownership
-
Established
1986-04-25
Employees
-
Market Cap
-
Website
http://www.shaxizhiyao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

195

NMPA:195

Drug Approvals

腰痛片

Approval Number
国药准字Z44023053
Approval Date
Apr 24, 2025
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H44023757
Approval Date
Jan 3, 2023
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H44023758
Approval Date
Jan 3, 2023
NMPA

生脉饮

Approval Number
国药准字Z44023144
Approval Date
Nov 4, 2021
NMPA

玉屏风口服液

Approval Number
国药准字Z44020235
Approval Date
Nov 4, 2021
NMPA

咳特灵胶囊

Approval Number
国药准字Z44020505
Approval Date
Aug 6, 2021
NMPA

复方感冒灵片

Approval Number
国药准字Z44023042
Approval Date
Aug 6, 2021
NMPA

感冒清胶囊

Approval Number
国药准字Z44020501
Approval Date
Aug 6, 2021
NMPA

腹可安片

Approval Number
国药准字Z44023045
Approval Date
Aug 6, 2021
NMPA

知柏地黄丸

Approval Number
国药准字Z44023148
Approval Date
Jul 30, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 20
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.